← Back to Patent Explorer
US4078564A Expired / Lapsed US ⏱️ 0.0 years remaining

Intralenticular cataract surgery

Assignee: Novo Enzyme Corp
•
Filing: 1976-02-24
•
Granted: 1978-03-14
•
Expires: 1996-02-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An enzymatic intralenticular cataract treatment for removal of nuclear cortical and subcapsular regions of the cataractous lens through enzymatic digestion thereof which comprises introduction of a concentrated solution of mixed exogenous enzymes into the nuclear and cortical regions of a cataractous lens, and after enzymatic digestion removing the liquefied cataractous material. The procedure allows removal of the nuclear, cortical and subcapsular portions of a cataractous lens through a very tiny incision in the eye and lens capsule, leaving all other structures within the eye intact.

Inventors

  • 👤 Joseph Spina
  • 👤 Michael K. Weibel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 22:11
CPC Classifications
A; A61; A61F; A61F9/00; A61F9/007; A61F9/00736; A61M; A61M5/00; A61M5/178; A61M5/31; A61P; A61P27/00; A61P27/02; A61P27/12; A61M2210/00; A61M2210/06; A61M2210/0612

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 47 words
A method for enzymatically treating cataracts in vivo which comprises injecting a concentrated solution of at least one exogenous lens digesting enzyme directly into the lens of an eye, then allowing enzymatic digestion of the lens to take place and thereafter removing the enzyme digested lens material.
Claim 2
Independent Claim 47 words
A method for enzymatically treating cataracts in vivo which comprises injecting a concentrated solution of at least one exogenous lens digesting enzyme directly into the lens of an eye, then allowing enzymatic digestion of the lens to take place and thereafter removing the enzyme digested lens material.
Claim 3
Dependent Claim 23 words
The method of claim 1 including the step of injecting an enzyme solution including at least one protease, a lipae and a phospholipase.
Claim 4
Dependent Claim 18 words
The method of claim 1 including the step of injecting an enzyme solution including a multiplicity of proteases.
Claim 5
Dependent Claim 17 words
The method of claim 1 including the step of incorporating a tracking indicator in the enzyme solution.
Claim 6
Dependent Claim 36 words
The method of claim 1 including, after the step of injecting the enzyme solution the step of injecting an air bubble into the injection opening, sealing same against leakage of the enzyme solution from the lens.

References Cited (Backward Citations)

US3320131A Cited
US3589363A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-03-13 1981-09-12 1982-03-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-03-13 1985-09-12 1986-03-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-03-13 1989-09-12 1990-03-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag